Generation of a New Humanized Pompe Disease Model for Improved Robust // Pre-Clinical Evaluation of new Pompe Therapeutics
Comprehensive Immunogenetic Analysis of Long COVID Reveals HLA-B*15 as an Independent Protective Factor.Autores: Cano-Perales JL, Ortuño Pastor PJ, Rosales-Castillo A, Bernal M, Vilchez JR, Jimenez P, Marín-Sánchez A, Rodriguez-Nicolas A, Lizama-Muñoz A, Ballesta L, Sainz J, Ruiz-Cabello F, López-Nevot MA, Gutiérrez-Bautista JF11/2026 - HLA
Molecular Profiling and Precision Oncology for Non-Small Cell Lung Cancer in Latin America: Unique Epidemiology, Persistent Barriers, and Paths Toward Equity.Autores: Picón CR, Borea R, Rizzo MM, Minatta JN, Amorin RI, Pandolfi JB, Cardona AF, Arrieta O, Enrico D, Voza A, Denninghoff V, Rolfo C11/2026 - Journal of immunotherapy and precision oncology
Circulating Tumour Cell GALNT13 Expression Is Associated with Prognosis and Treatment Response in Non-Small Cell Lung Cancer.Autores: Fernández Armúa E, Serrano MJ, Santana D, Carrasco M, Molina MP, Aznar I, Acosta M, Villar B, Ferrari J, Touya D, Osinaga E, Berois N10/2026 - International journal of molecular sciences